Author:
Schrama J G,Holtkamp M J,Baars J W,Schornagel J H,Rodenhuis S
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Anderson LW, Chen TL, Colvin OM, Grochow LB, Collins JM, Kennedy MJ, Strong JM (1996) Cyclophosphamide and 4-hydroxyphosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy. Clin Cancer Res 2: 1481–1487
2. Antman KH, Ayash, Elias A, Wheeler C, Hunt M, Eder JP, Teider BA, Critchlow J, Bibbo J, Schnipper LE, Frei III E (1992) A phase II study of high-dose cyclophosphamide, thiotepa and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. J Clin Oncol 10: 102–110
3. Antman KH, Rowlings PA, Vaughan WP, Pelz CJ, Fay JN, Fields KK, Freytas CO, Gale RP, Hillner BE, Holland HK, Kennedy MJ, Klein JP, Lazarus HM, Mc Carthy Jr PL, Saez L, Spitzer G, Stadtmauer GA, Williams ST, Wolff S, Sobienski KA, Armitrage JO, Horowitz MM (1997) High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol 15: 1870–1879
4. Bergh J, Wiklund T, Erikstein B, Lidbrink E, Lindman H, Malmstrom P, Kellokumpu-Lehtinen P, Bengtsson NO, Soderlund G, Anker G, Wist E, Ottosson S, Salminin E, Ljungman P, Holte H, Nilsson J, Blomqvist C, Wilking N (2000) Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study. Lancet 356: 1384–1391
5. De Gast GC, Vyth-Dreese FA, Nooijen W, van den Bogaard CJ, Sein J, Holtkamp MM, Linthorst GA, Baars JW, Schornagel JH, Rodenhuis S (2002) Reinfusion of autologous lymphocytes with granulocyte–macrophage colony-stimulating factor induces rapid recovery of CD4+ and CD8+ T cells after high-dose chemotherapy for metastatic breast cancer. J Clin Oncol 20: 58–64
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献